Mounjaro and Oral Contraceptives: Does Tirzepatide Affect the Pill?

If you take the combined oral contraceptive pill and are starting Mounjaro (tirzepatide), you need to know about a clinically important interaction. Tirzepatide slows gastric emptying, which can reduce how well your body absorbs oral medications, including the pill.

This is not a theoretical concern. Pharmacokinetic studies show that tirzepatide can reduce the peak concentration of ethinyl oestradiol by up to 59% after an initial dose. The MHRA has issued formal guidance advising women to use additional barrier contraception during specific windows of Mounjaro treatment.

At CutKilo, every patient who takes oral contraception receives this guidance at their initial consultation. Here is what the evidence shows and what you should do.

Yes. Tirzepatide delays gastric emptying, which can reduce the absorption of oral contraceptive hormones. The effect is most pronounced when you first start Mounjaro and after each dose increase. The MHRA advises using a barrier method (such as condoms) or switching to a non-oral contraceptive for four weeks after starting treatment and four weeks after every dose escalation.

This does not mean Mounjaro makes the pill completely ineffective. It means there is a measurable reduction in hormone levels during these transition periods, and taking precautions is the responsible clinical approach.

Tirzepatide is a dual GIP and GLP-1 receptor agonist. One of its mechanisms of action is slowing the rate at which food and liquids leave your stomach, a process called delayed gastric emptying.

This slower stomach emptying is part of how Mounjaro helps with weight loss. It keeps you feeling fuller for longer and reduces the speed at which nutrients, including glucose, enter your bloodstream.

However, this same mechanism affects how quickly your body absorbs oral medications. If a tablet sits in your stomach for longer than expected, the hormones it contains may not reach your bloodstream at the right rate or in the right concentration for full effectiveness. This absorption effect applies to other oral medications too. We have covered the specific interaction with Mounjaro and levothyroxine in a separate guide.

The effect on gastric emptying is strongest when you first start tirzepatide and when you increase your dose. Over time, as your body adjusts, the degree of gastric slowing tends to diminish. This is why the precautionary window is limited to the first four weeks of each new dose.

Eli Lilly conducted a pharmacokinetic study in 40 women on stable oral contraceptive therapy. After a single 5 mg dose of tirzepatide, researchers measured the blood levels of the contraceptive hormones ethinyl oestradiol and norgestimate.

The results were significant. Peak concentration (Cmax) of ethinyl oestradiol fell by 59%. Peak concentration of norelgestromin (the active metabolite of norgestimate) fell by 55%. Overall exposure (AUC) declined by approximately 20 to 23% for both hormones. The time to reach peak levels was delayed by 2.5 to 4.5 hours.

These reductions matter because oral contraceptives rely on maintaining consistent hormone levels to suppress ovulation. A 59% drop in peak concentration, even if temporary, could theoretically allow a breakthrough ovulation event.

Importantly, when the same study looked at the effects after four consecutive weekly doses (5 mg, 5 mg, 8 mg, 10 mg), the impact on contraceptive absorption was no longer statistically significant. This suggests the body adapts, but the early weeks of each new dose remain the highest risk period.

The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has issued clear guidance on this interaction. Women taking oral hormonal contraceptives alongside tirzepatide should use an additional barrier method of contraception (such as condoms) or switch to a non-oral contraceptive method for four weeks after starting Mounjaro and for four weeks after each dose increase.

Australia’s Therapeutic Goods Administration (TGA) and New Zealand’s Medsafe have issued similar recommendations. The US FDA prescribing information for both Mounjaro and Zepbound includes this interaction in the drug labelling.

At CutKilo, we discuss this interaction at the first consultation. If you are already on the pill when you begin treatment, we recommend speaking with your GP or prescriber about whether to add a barrier method or consider an alternative contraceptive.

The interaction only applies to oral contraceptives because delayed gastric emptying causes the absorption issue. Contraceptive methods that bypass the digestive system entirely tirzepatide does not affect.

Non-oral methods that are unaffected include the hormonal coil (Mirena or similar levonorgestrel IUS), the contraceptive implant (Nexplanon), the contraceptive injection (Depo-Provera), the copper IUD, and the vaginal ring (NuvaRing). Condoms, whether used alone or as a backup method, are also entirely unaffected.

If you are planning to start Mounjaro and want a contraceptive method that does not interact with your treatment, a long-acting reversible contraceptive (LARC) such as an implant or IUS is the most reliable option. These methods also have the advantage of not requiring daily adherence, which simplifies your routine during weight loss treatment.

If you are currently taking the combined pill or the progesterone-only pill and are about to start Mounjaro, there are a few practical steps to follow.

First, tell your prescribing doctor that you are on oral contraception. At CutKilo, this is part of our standard medical questionnaire, but if you are accessing Mounjaro through another provider, make sure they know.

Second, use a barrier method (condoms) as additional contraception for the first four weeks after your initial Mounjaro injection. Repeat this precaution for four weeks after every dose increase, not just the first one.

Third, consider discussing long-term contraceptive alternatives with your GP. If you plan to be on Mounjaro for several months, switching to a non-oral method removes the interaction concern entirely.

Fourth, do not stop taking your oral contraceptive. The pill still provides partial protection even with reduced absorption. Stopping it altogether while relying on no other method would be less safe, not more. If you are planning a pregnancy during or after Mounjaro treatment, read our guide on Mounjaro and fertility for important timing considerations.

Does Mounjaro make the pill completely ineffective?

No. The pharmacokinetic data shows a reduction in absorption, not a total block. Peak hormone levels fall, but overall exposure declines by around 20%. The MHRA advises additional precautions rather than abandoning the pill entirely.

Do I need to use extra contraception at every dose, or just the first one?

At every dose increase. The MHRA guidance is to use a barrier method for four weeks after starting Mounjaro and four weeks after each dose escalation. Once you are stable on a dose for more than four weeks, the interaction effect diminishes.

Does this interaction apply to the progesterone-only pill (mini pill)?

Researchers conducted the studies with combined oral contraceptives (ethinyl oestradiol and norgestimate). Researchers did not specifically test the progesterone-only pill, but since it is also absorbed orally, the same precautionary principle applies. Discuss this with your prescriber.

Is the contraceptive patch or vaginal ring affected?

The contraceptive patch delivers hormones through the skin, bypassing the digestive system, so delayed gastric emptying does not affect it. The vaginal ring (NuvaRing) delivers hormones locally through vaginal mucosa and is also unaffected.

What about HRT (hormone replacement therapy)?

Oral HRT tablets delayed gastric emptying could theoretically affect in the same way. If you are on oral HRT, speak to your doctor about whether switching to a patch or gel formulation would be appropriate while on Mounjaro.

The interaction between Mounjaro and oral contraceptives is real, measurable, and well documented. Tirzepatide causes this by slowing gastric emptying, which reduces how well your body absorbs oral hormones during the first weeks of treatment and after each dose increase.

The solution is straightforward. Use a barrier method for four weeks after starting Mounjaro and after each dose escalation, or switch to a non-oral contraceptive method that bypasses the gut entirely.

At CutKilo, we raise this with every patient who takes oral contraception. It is a manageable interaction, but it requires awareness and a clear plan. If you have any concerns, your CutKilo clinician can advise you during your regular check-in.